Publication Cover
Redox Report
Communications in Free Radical Research
Volume 13, 2008 - Issue 5
809
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Changes of markers of oxidative stress during menstrual cycle

, , , &
Pages 237-240 | Published online: 19 Jul 2013

References

  • Varma SD, Devamanoharan PS. Excretion of hydrogen peroxide in human urine. Free Radic Res Commun 1990; 8: 73–78.
  • Long LH, Evans PJ, Halliwell B. Hydrogen peroxide in human urine: implications for antioxidant defense and redox regulation. Biochem Biophys Res Commun 1999; 262: 605–609.
  • Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004; 142: 231-255.
  • Yuen JW, Benzie IF. Hydrogen peroxide in urine as a potential biomarker of whole body oxidative stress. Free Radic Res 2003; 37: 1209–1213.
  • Banerjee D, Jacob J, Kunjamma G, Madhusoodanan UK, Ghosh S. Measurement of urinary hydrogen peroxide by FOX-1 method in conjunction with catalase in diabetes mellitus - a sensitive and specific approach. Clin Chim Acta 2004; 350: 233–236.
  • Banerjee D, Madhusoodanan UK, Nayak S, Jacob J. Urinary hydrogen peroxide: a probable marker of oxidative stress in malignancy. Clin Chim Acta 2003; 334: 205–209.
  • Mathru M, Rooney MW, Dries DJ, Hirsch LJ, Barnes L, Tobin MJ. Urine hydrogen peroxide during adult respiratory distress syndrome in patients with and without sepsis. Chest 1994; 105: 232–236.
  • Hiramoto K, Kida T, Kikugawa K. Increased urinary hydrogen peroxide levels caused by coffee drinking. Biol Pharm Bull 2002; 25: 1467–1471.
  • Long LH, Clement MV, Halliwell B. Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media. Biochem Biophys Res Commun 2000; 273: 50–53.
  • Tsukahara H. Biomarkers for oxidative stress: clinical application in pediatric medicine. Curr Med Chem 2007; 14: 339–351.
  • Meagher EA, FitzGerald GA. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 2000; 28: 1745–1750.
  • Guichardant M, Valette-Talbi L, Cavadini C, Crozier G, Berger G. Malondialdehyde measurement in urine. J Chromatogr 1994; 655: 112–116.
  • Kosugi H, Enomoto H, Ishizuka Y, Kikigawa K. Variations in the level of thiobarbituric acid reactant in healthy humans under different physiological conditions. Biol Pharm Bull 1994; 17: 1645–1650.
  • Gay CA, Gebicki JM. Perchloric acid enhances sensitivity and reproducibility of the ferric-xylenol orange peroxide assay. Anal Biochem 2002; 304: 42–46.
  • Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745–2756.
  • Hare RS. Endogenous creatinine in serum and urine. Proc Soc Exp Biol Med 1950; 74: 148–151.
  • Goulart M, Batoréu MC, Rodrigues AS, Laires A, Rueff J. Lipoperoxidation products and thiol antioxidants in chromium exposed workers. Mutagenesis 2005; 20: 311–315.
  • Mazière C, Auclair M, Mazière JC. Lipophilic beta-blockers inhibit monocyte and endothelial cell-mediated modification of low density lipoproteins. Biochim Biophys Acta 1992; 1126: 314–318.
  • Rifici VA, Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol. Metabolism 1992; 41: 1110–1114.
  • Hwang J, Rouhanizadeh M, Hamilton RT et al. 17-beta-Estradiol reverses shear-stress-mediated low density lipoprotein modifications. Free Radic Biol Med 2006; 41: 568–578.
  • Hwang J, Peterson H, Hodis HN, Choi B, Sevanian A. Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation. Atherosclerosis 2000; 150: 275–284.
  • Shwaery GT, Vita JA, Keaney JFJ. Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol. Atherosclerosis 1998; 138: 255–262.
  • Arteaga E, Rojas A, Duran D. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women. Menopause 1998; 5: 16–23.
  • Windler E. Modification of serum lipids and cardiovascular risk by estrogenic active compounds. Gynecol Endocrinol 1999; 13 (Suppl 6): 21–28.
  • Manthey D, Behl C. From structural biochemistry to expression profiling: neuroprotective activities of estrogen. Neuroscience 2006; 138: 845–850.
  • Vina J, Borras C, Gomez-Cabrera MC, Orr WC. Part of the series: from dietary antioxidants to regulators in cellular signalling and gene expression. Role of reactive oxygen species and (phyto)oestrogens in the modulation of adaptive response to stress. Free Radic Res 2006; 40: 111–119.
  • Bonds C, Sastre J, Garcia-Sala D, Lloret A, Pallardó FV, Villa J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003; 34: 546–552.
  • Villa J, Sastre J, Pallardó F, Borras C. Mitochondrial theory of aging: importance to explain why females live longer than males. Antioxid Redox Signal 2003; 5: 549–556.
  • Bonds C, Gambini J, Gómez-Cabrera MC et al. 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell 2005; 4: 113–118.
  • Borras C, Gambini J, Vina J. Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci 2007; 12: 1008–1013.
  • Dabrosin C, Ollinger K. Variability of glutathione during the menstrual cycle - due to estrogen effects on hepatocytes? Free Radic Biol Med 2004; 36: 145–151.
  • Lutoslawska G, Tkaczyk J, Panczenko-Kresowska B, Hubner-Wozniak E, Skierska E, Gajewski AK. Plasma TBARS, blood GSH concentrations, and erythrocyte antioxidant enzyme activities in regularly menstruating women with ovulatory and anovulatory menstrual cycles. Clin Chim Acta 2003; 331: 159–163.
  • Palan PR, Magneson AT, Castillo M, Dunne J, Mikhail MS. Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants. Am J Obstet Gynecol 2006; 194: e35–e38.
  • Joo MH, Maehata E, Adachi T, Ishida A, Murai F, Mesaki N. The relationship between exercise-induced oxidative stress and the menstrual cycle. Eur J Appl Physiol 2004; 93: 82–86.
  • Ruiz-Sanz JI, Navarro R, Martinez R, Hernández ML, Matorras R, Ruiz-Larrea MB. No effect of menstrual cycle on LDL oxidizability and particle size. Maturitas 2007; 57: 253–260.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.